Study title: A randomized, multicenter, double blind study to evaluate the effect of adding montelukast sodium to inhaled budesonide compared to doubling the dose of inhaled budesonide in adult patients with asthma
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases | |||||
Brands: Please see report, Please see report, Please see report | |||||
MAH holders: Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: MONTELUKAST | |||||
ATC code: | |||||
Document link: 909.pdf | |||||
Document date: 2011-09-29 | |||||
Study number: Protocol 909 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |